Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Novartis AG (NVSEF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
90.2400 0.0000    0.00%
18/04 - Delayed Data. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 90.2400 - 90.2400
Novartis 90.2400 0.0000 0.00%

NVSEF Ratios

 
Assess the performance of Novartis (NOVN). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Novartis AG's latest financial reports. Compare the performance metrics of Novartis (NOVN) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 23.8 91.85
Price to Sales TTM 4.37 8.18
Price to Cash Flow MRQ 14.1 30.57
Price to Free Cash Flow TTM 15.22 49.83
Price to Book MRQ 4.37 14.32
Price to Tangible Book MRQ 114.63 238.74
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 74.24% 70.9
Gross Margin 5YA 71.65% 45.66
Operating margin TTM 27.09% -17.67
Operating margin 5YA 24.17% -26.14
Pretax margin TTM 19.55% -29.25
Pretax margin 5YA 25.72% -34.1
Net Profit margin TTM 31.83% -30.57
Net Profit margin 5YA 25.32% -37.85
   
Revenue/Share TTM 22.7 169.59
Basic EPS ANN 7.15 17.74
Diluted EPS ANN 7.1 17.66
Book Value/Share MRQ 22.7 160.77
Tangible Book Value/Share MRQ 0.87 20.37
Cash/Share MRQ 6.52 27.1
Cash Flow/Share TTM 7.03 28.91
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 16.16% 31.28
Return on Equity 5YA 19.17% 38.28
Return on Assets TTM 13.67% 10.04
Return on Assets 5YA 9.92% 10.81
Return on Investment TTM 13.7% 20.99
Return on Investment 5YA 11.69% 21.66
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 0% -29.4
EPS(TTM) vs TTM 1 Yr. Ago TTM 124.25% 21.31
5 Year EPS Growth 5YA 5.63% 3.62
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 0% 14.71
Sales (TTM) vs TTM 1 Yr. Ago TTM 7.36% 23.09
5 Year Sales Growth 5YA 0.24% 7.81
5 Year Capital Spending Growth 5YA -3.31% 4.2
   
Quick Ratio MRQ 0.8 0.76
Current Ratio MRQ 1.16 1.02
LT Debt to Equity MRQ 39.51% 91.21
Total Debt to Equity MRQ 56.65% 93.44
Efficiency    
Asset Turnover TTM 0.43 0.42
Inventory Turnover TTM 1.84 3.9
Revenue/Employee TTM 613.49K 8.37M
Net Income/Employee TTM 195.30K 1.20M
Receivable Turnover TTM 6.56 3.35
   
Dividend Yield ANN - 1.78
Dividend Yield 5 Year Avg. 5YA 4.28% 2.89
Dividend Growth Rate ANN 0% 31.14
Payout Ratio TTM 48.86% 29.25
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVN Comments

Write your thoughts about Novartis AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Pablo Germain
Pablo Germain Jan 10, 2023 1:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Could someone explain to me today's -2%?
Mr Ride
MrRide Jan 10, 2023 1:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Citi analyst downgraded Novartis (SW) (NVS) from Buy to Neutral with a price target of CHF86.00 (from CHF95.00).
Chemsedine Bendaci
Chemsedine Bendaci Feb 02, 2022 2:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great results coming
Chemsedine Bendaci
Chemsedine Bendaci Jan 12, 2022 6:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
price target 116.34 according to zone bourse
Michael Näf
Michael Näf Feb 24, 2021 6:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now good price to go in!
Vima OG
Vima OG Feb 26, 2020 11:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Long term.
Kristof Mouton
Stoffel Sep 17, 2019 4:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
before investing in @novartis, read #teampia (twitter).
MoneyManager MoneyManager
Money2Manage4U Sep 17, 2019 4:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what refers ?
José Spescha
José Spescha Sep 17, 2019 4:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I can not open #teampia. What is the conclusion?
Toni Fluxá
Toni Fluxá Apr 10, 2019 8:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
botton at 81
Levo Goldberg
Levo Goldberg Apr 10, 2019 8:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hope so loaded heavily at 85....
Brunello Pianca
Brunello Pianca Jan 15, 2019 12:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
must hold 83.50 for uptrend to resume
Tomas Lysak DiS
Tomas Lysak DiS Aug 23, 2018 7:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes. Novartis is a good company with solid numbers.
Shadow Trader
ShadowTrader Sep 10, 2017 8:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice time to buy ? I'm not pretty sure... any one can say something about. ?. thanks to all
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email